...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Biotech Showcase

Noretreat,

Thanks in advance for letting us know you will be attending Biotech Showcase. We look forward to any info you may share with us about both the Resverlogix presentation yesterday and the Zenith presentation today (9:15 AM Pacific). Good luck to Zenith!

BDAZ

Share
New Message
Please login to post a reply